Almond ingestion at mealtime reduces postprandial glycemia and chronic ingestion reduces hemoglobin A1c in individuals with well-controlled type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 60, Issue 9, 2011, Pages 1312-1317

  Cohen, Ashley E ^a   Johnston, Carol S ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C;

ALMOND; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES CONTROL; DIABETIC PATIENT; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INSULINEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 80051788667     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.01.017     Document Type: Article

References (32)

1. Li T.Y., Brennan A.M., and Wedick N.M. Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes J Nutr 139 2009 1333 1338
2. Hu F.B., and Stampfer M.J. Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence Curr Atheroscler Rep 1 1999 204 209
3. Jiang R., Manson J.E., and Stampfer M.J. Nut and peanut butter consumption and risk of type 2 diabetes in women J Am Med Assoc 288 2002 2554 2560 (Pubitemid 35386890)
4. Kochar J., Gaziano J.M., and Djousse L. Nut consumption and risk of type II diabetes in the Physicians' Health Study Eur J Clin Nutr 64 2010 75 79
5. Parker E.D., Harnack L.J., and Folsom A.R. Nut consumption and risk of type 2 diabetes J Am Med Assoc 290 2003 38 39
6. Lovejoy J.C., Most M.M., and Lefevre M. Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes Am J Clin Nutr 76 2002 1000 1006 (Pubitemid 35244670)
7. Tapsell L.C., Batterham M.J., and Teuss G. Long-term effects of increased dietary polyunsaturated fat from walnuts on metabolic parameters in type II diabetes Eur J Clin Nutr 63 2009 1008 1015
8. Jenkins D.J.A., Kendall C.W.C., and Josse A.R. Almonds decrease postprandial glycemia, insulinemia, and oxidative damage in healthy individuals J Nutr 136 2006 2987 2992 (Pubitemid 44878561)
9. Josse A.R., Kendall C.W.C., and Augustin L.S.A. Almonds and postprandial glycemia-a dose-response study Metab Clin Exp 56 2007 400 404 (Pubitemid 46209230)
10. Cassady B.A., Hollis J.H., and Fulford A.D. Mastication of almonds: effects of lipid bioaccessibility, appetite, and hormone response Am J Clin Nutr 89 2009 794 800
11. Vollmer K., Holst J.J., and Baller B. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance Diabetes 57 2008 678 687
12. Aydin S. A comparison of ghrelin, glucose, alpha-amylase and protein levels in saliva from diabetics J Biochem Mol Biol 40 2007 29 35 (Pubitemid 46182732)
13. Dodds M.W., and Dodds A.P. Effects of glycemic control on saliva flow rates and protein composition in non-insulin-dependent diabetes mellitus Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 1997 465 470 (Pubitemid 127671862)
14. Yavuzyilmaz E., Yumak O., and Akdoǧanli T. The alterations of whole saliva constituents in patients with diabetes mellitus Aust Dent J 41 1996 193 197 (Pubitemid 126474171)
15. Skude G., and Ihse I. Salivary amylase in duodenal aspirates Scand J Gastroenterol 11 1976 17 20
16. Kawamori R., Katsura M., and Ishida S. Subclinical exocrine pancreatic derangement in human diabetic patients evaluated from pure pancreatic juice J Diabetes Complications 9 1995 69 73
17. Lo Piparo E., Scheib H., and Frei N. Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase J Med Chem 51 2008 3555 3561 (Pubitemid 351875010)
18. Milbury P.E., Chen C.Y., and Dolnikowski G.G. Determination of flavonoids and phenolics and their distribution in almonds J Agric Food Chem 54 2006 5027 5033 (Pubitemid 44140898)
19. Li S.C., Liu Y.H., and Liu J.F. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus Metabolism 2010 [Epub ahead of print]
20. Wien M., Bleich D., and Raghuwanshi M. Almond consumption and cardiovascular risk factors in adults with prediabetes J Am Coll Nutr 29 2010 189 197
21. Bode B.W. Defining the importance of daily glycemic control and implications for type 2 diabetes management Postgrad Med 121 2009 82 93
22. Kohnert K.D., Augstein P., and Heinke P. Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes Diabetes Res Clin Pract 77 2007 420 426 (Pubitemid 47211341)
23. Heine R.J., Balkau B., and Ceriello A. What does postprandial hyperglycaemia mean? Diabet Med 21 2004 208 213 (Pubitemid 38299612)
24. Banel D.K., and Hu F.B. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review Am J Clin Nutr 90 2009 56 63
25. White J. Efficacy and safety of incretin based therapies: clinical trial data J Am Pharm Assoc 49 Suppl 1 2009 S30 S40
26. Göke B. German Pioglitazone Study Group Improved glycemic control and lipid profile in a randomized study of pioglitazone compared with acarbose in patients with type 2 diabetes mellitus Treat Endocrinol 1 2002 329 336 (Pubitemid 37047237)
27. Hanefeld M., Chiasson J.L., and Koehler C. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance Stroke 35 2004 1073 1078 (Pubitemid 38543520)
28. Zeymer U., Schwarzmaier-D'assie A., and Petzinna D. Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy Eur J Cardiovasc Prev Rehabil 11 2004 412 415 (Pubitemid 39491062)
29. Brennan A.M., Sweeney L.L., and Liu X. Walnut consumption increases satiation but has no effect on insulin resistance or the metabolic profile over a 4-day period Obesity (Silver Spring) 18 2010 1176 1182
30. Toft-Nielsen M.B., Damholt M.B., and Madsbad S. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients J Clin Endocrinol Metab 86 2001 3717 3723 (Pubitemid 32755966)
31. Kris-Etherton P.M., Pearson T.A., and Wan Y. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations Am J Clin Nutr 70 1999 1009 1015
32. Cheng A.Y.Y., and Leiter L.A. Glucose lowering and cardiovascular disease: what do we know and what should we do? Eur J Cardiovasc Prev Rehabil 17 Suppl 1 2010 S25 S31